SP
SPIMACO
Riyadh SAFounded 19863,500 employees
Private CappharmaPrivateOncologyInfectious Disease
Platform: Saudi Pharma
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Liravorutinib | SPI-5919 | Approved | 3 | CD47 | GAIPF | ||
| Lisotuximab | SPI-932 | Phase 1 | 1 | MET | PBCDravet |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)